financetom
Business
financetom
/
Business
/
Middleby Fiscal Q2 Adjusted Earnings, Sales Fall; Q3, Full-Year Guidance Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Middleby Fiscal Q2 Adjusted Earnings, Sales Fall; Q3, Full-Year Guidance Set
Aug 6, 2025 5:13 AM

07:46 AM EDT, 08/06/2025 (MT Newswires) -- Middleby ( MIDD ) reported fiscal Q2 adjusted earnings Wednesday of $2.35 per diluted share, down from $2.39 a year earlier.

Analysts polled by FactSet expected $2.23.

Net sales for the quarter ended June 28 were $977.9 million, compared with $991.5 million a year earlier.

Analysts polled by FactSet expected $974.8 million.

The company said it expects Q3 adjusted EPS of $2.04 to $2.19 on revenue of $950 million to $975 million. Analysts are looking for $2.27 and $969.7 million, respectively.

Middleby ( MIDD ) expects 2025 adjusted EPS of $8.65 to $9.05 on revenue of $3.81 billion to $3.87 billion. Analysts are looking for $9.25 and $3.88 billion, respectively.

The company's shares were up 1% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Pfizer explores sale of hospital drugs unit, sources say
Exclusive-Pfizer explores sale of hospital drugs unit, sources say
Nov 12, 2024
NEW YORK (Reuters) - Pfizer ( PFE ) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter. The unit, now called Pfizer Hospital, was formed after Pfizer ( PFE ) bought Hospira for about...
Resmed Insider Sold Shares Worth $3,615,821, According to a Recent SEC Filing
Resmed Insider Sold Shares Worth $3,615,821, According to a Recent SEC Filing
Nov 12, 2024
05:41 PM EST, 11/12/2024 (MT Newswires) -- Michael J. Farrell, Chief Executive Officer, on November 07, 2024, sold 14,683 shares in Resmed ( RMD ) for $3,615,821. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,344 shares of the company, with 464,254 shares held directly and 4,090 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/xslF345X05/form4.xml ...
ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised
ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised
Nov 12, 2024
05:15 PM EST, 11/12/2024 (MT Newswires) -- ICU Medical ( ICUI ) reported Q3 adjusted earnings late Tuesday of $1.59 per diluted share, up from $1.57 a year earlier. Analysts polled by Capital IQ expected $1.25. Revenue for the quarter ended Sept. 30 was $589.1 million, up from $553.3 million a year earlier. Analysts surveyed by Capital IQ expected $576.7...
Kraft-Heinz pulls key Lunchables meals from U.S. free- and low-cost school lunch program
Kraft-Heinz pulls key Lunchables meals from U.S. free- and low-cost school lunch program
Nov 12, 2024
NEW YORK (Reuters) - Kraft Heinz is no longer making its packaged lunch brand Lunchables for low-income students receiving free and reduced-priced meals from a federal program, according to a company statement, the latest blow to one of the company's most iconic products. Chicago-based Kraft Heinz announced plans to sell to the school lunch program early last year at an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved